MX2013007191A - Metodos y composiciones para prevenir y tratar la osteoartritis. - Google Patents

Metodos y composiciones para prevenir y tratar la osteoartritis.

Info

Publication number
MX2013007191A
MX2013007191A MX2013007191A MX2013007191A MX2013007191A MX 2013007191 A MX2013007191 A MX 2013007191A MX 2013007191 A MX2013007191 A MX 2013007191A MX 2013007191 A MX2013007191 A MX 2013007191A MX 2013007191 A MX2013007191 A MX 2013007191A
Authority
MX
Mexico
Prior art keywords
preventing
methods
compositions
treating osteoarthritis
treating
Prior art date
Application number
MX2013007191A
Other languages
English (en)
Inventor
Rondo Paul Middleton
Mark Kenneth Waldron
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2013007191A publication Critical patent/MX2013007191A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención proporciona métodos para prevenir y tratar la osteoartritis, prevenir y tratar la degradación del cartílago articular, y fomentar y mantener la salud articular en un animal. Los métodos comprenden la administración de ADGL a los animales, preferentemente en cantidades desde alrededor de 0.01 hasta alrededor de 100 mg/kg/día.
MX2013007191A 2010-12-21 2011-12-15 Metodos y composiciones para prevenir y tratar la osteoartritis. MX2013007191A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061459902P 2010-12-21 2010-12-21
PCT/US2011/065173 WO2012087745A1 (en) 2010-12-21 2011-12-15 Methods and compositions for preventing and treating osteoarthritis

Publications (1)

Publication Number Publication Date
MX2013007191A true MX2013007191A (es) 2013-07-12

Family

ID=46314373

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013007191A MX2013007191A (es) 2010-12-21 2011-12-15 Metodos y composiciones para prevenir y tratar la osteoartritis.

Country Status (11)

Country Link
US (1) US20140205569A1 (es)
EP (1) EP2654744A4 (es)
JP (1) JP2014505679A (es)
CN (1) CN103384521A (es)
AU (1) AU2011349718B2 (es)
BR (1) BR112013018453A2 (es)
CA (1) CA2822263A1 (es)
MX (1) MX2013007191A (es)
RU (1) RU2013133998A (es)
WO (1) WO2012087745A1 (es)
ZA (1) ZA201305497B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
WO2014022816A2 (en) * 2012-08-03 2014-02-06 Dignity Sciences Limited Pharmaceutical compositions comprising 15-hetre and methods of treating or preventing arthritis using same
BR112016028518A2 (pt) 2014-06-04 2017-08-22 Dignity Sciences Ltd composições farmacêuticas que compreendem dgla e uso do mesmo

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE49783B1 (en) * 1979-05-18 1985-12-11 Efamol Ltd Pharmaceutical and dietary composition comprising epsilon-linolenic acids
GB9403857D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
GB9403855D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
JP4111542B2 (ja) * 1995-08-07 2008-07-02 サントリー株式会社 軟骨組織の異常に起因する疾患の予防又は治療薬
GB9622636D0 (en) * 1996-10-30 1997-01-08 Scotia Holdings Plc Presentation of bioactives
GB9710351D0 (en) * 1997-05-20 1997-07-16 Scotia Holdings Plc Glucosamine fatty acids
WO2001090311A1 (en) * 2000-05-25 2001-11-29 Societe Des Produits Nestle S.A. Novel probiotics for pet food applications
US20020188024A1 (en) * 2000-08-23 2002-12-12 Chilton Floyd H. Fatty acid-containing emulsion with increased bioavailability
RU2422140C2 (ru) * 2003-08-11 2011-06-27 Хилл'С Пет Ньютришн, Инк. Применение омега-3 жирных кислот при лечении остеоартрита у псовых
US8633247B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
BRPI0416809A (pt) * 2003-11-21 2007-01-09 Nestec Sa glicosamina
WO2006002976A2 (en) * 2004-07-01 2006-01-12 Nestec S.A. Canine osteoarthritis diet formulation
EP1852114B1 (en) * 2005-02-14 2019-09-18 Suntory Holdings Limited Composition containing dihomo-y-linolenic acid (dgla) as active ingredient
EP2007406A2 (en) * 2006-04-03 2008-12-31 Nestec S.A. Nutritional compositions for promotion of bone growth and maintenance of bone health and methods regarding same

Also Published As

Publication number Publication date
US20140205569A1 (en) 2014-07-24
ZA201305497B (en) 2015-01-28
EP2654744A4 (en) 2014-07-02
RU2013133998A (ru) 2015-01-27
CN103384521A (zh) 2013-11-06
AU2011349718B2 (en) 2017-02-09
AU2011349718A1 (en) 2013-07-04
WO2012087745A1 (en) 2012-06-28
CA2822263A1 (en) 2012-06-28
EP2654744A1 (en) 2013-10-30
BR112013018453A2 (pt) 2018-05-22
JP2014505679A (ja) 2014-03-06

Similar Documents

Publication Publication Date Title
MX344238B (es) Compuestos de tetrazol y métodos para preparar y usar los mismos.
IN2012DN02735A (es)
IN2012DN02730A (es)
IN2012DN00754A (es)
EA200900211A1 (ru) Замещенные производные имидазолона, их получение и применение
IN2012DN02624A (es)
MX351670B (es) Bacteria bacillus para uso en tratar y prevenir infecciones en animales acuaticos.
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
JO3313B1 (ar) التراكيب والطرق لزيادة نمو العضلة
MX339201B (es) Compuestos de sulfonamida y métodos para elaborarlos y usarlos.
MX337575B (es) Compuestos de sulfona y métodos para lafabricación y uso de éstos.
MX345535B (es) Compuestos tricíclicos parcialmente saturados y métodos para su fabricación y su uso.
NZ602478A (en) Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
MX2012006430A (es) Preparaciones de combinacion que comprenden un antagonista de citocina y un corticosteroide.
MX2013008729A (es) Metodos y composiciones para tratar, reducir, o prevenir el deterioro del sistema visual de los animales.
EA201592086A1 (ru) Жирная кислота таллового масла для использования в лечении и кормовые добавки и композиции для животных
GB2483419A (en) Formulations for the treatment of deep tissue pain
MX2013002947A (es) Composiciones de alimento para animales de acido abscisico.
IN2014CN04773A (es)
MX357166B (es) Anticuerpos que se unen a notum pectinacetilesterasa.
MX2013007191A (es) Metodos y composiciones para prevenir y tratar la osteoartritis.
EA201490032A1 (ru) Лиофилизированные препараты fgf-18
IN2012DN03187A (es)
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
MX2013013098A (es) Metodos y composiciones para fomentar el crecimiento de la masa corporal magra.